F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?

References

• Kornecki E, Walkowiak B, Naik UP, Ehrlich YH. Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem. 1990;265(17):10042–9. doi:10.1016/S0021-9258(19)38776-9. Epub 1990 Jun 15.
   PubMed Web of Science ®Google Scholar
• Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol. 1998;142(1):117–27. doi:10.1083/jcb.142.1.117. Epub 1998 Jul 14.
   PubMed Web of Science ®Google Scholar
• Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL. Identification and characterisation of human junctional adhesion molecule (JAM). Mol Immunol. 1999;36(17):1175–88. doi:10.1016/S0161-5890(99)00122-4. Epub 2000 Mar 04.
   PubMed Web of Science ®Google Scholar
• Azari BM, Marmur JD, Salifu MO, Cavusoglu E, Ehrlich YH, Kornecki E, Babinska A. Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis. Atherosclerosis. 2010;212(1):197–205. doi:10.1016/j.atherosclerosis.2010.05.014. Epub 2010 Jul 16.
   PubMed Web of Science ®Google Scholar
• Naik UP, Ehrlich YH, Kornecki E. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor. Biochem J. 1995;310(Pt 1):155–62. doi:10.1042/bj3100155. Epub 1995 Aug 15.
   PubMedGoogle Scholar
• Arrate MP, Rodriguez JM, Tran TM, Brock TA, Cunningham SA. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem. 2001;276(49):45826–32. doi:10.1074/jbc.M105972200. Epub 2001 Oct 09.
   PubMed Web of Science ®Google Scholar
• Sobocka MB, Sobocki T, Banerjee P, Weiss C, Rushbrook JI, Norin AJ, Hartwig J, Salifu MO, Markell MS, Babinska A, et al. Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood. 2000;95(8):2600–9. doi:10.1182/blood.V95.8.2600.
   PubMed Web of Science ®Google Scholar
• Mandell KJ, Parkos CA. The JAM family of proteins. Adv Drug Deliv Rev. 2005;57(6):857–67. doi:10.1016/j.addr.2005.01.005. Epub 2005 Apr 12.
   PubMed Web of Science ®Google Scholar
• Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof BA. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood. 2001;98(13):3699–707. doi:10.1182/blood.V98.13.3699. Epub 2001 Dec 12.
   PubMed Web of Science ®Google Scholar
• Bradfield PF, Nourshargh S, Aurrand-Lions M, Imhof BA. JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol. 2007;27(10):2104–12. doi:10.1161/ATVBAHA.107.147694. Epub 2007 Jul 7.
   PubMed Web of Science ®Google Scholar
• Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT, Chavakis T. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002;196(5):679–91. doi:10.1084/jem.20020267. Epub 2002 Sep 5.
   PubMed Web of Science ®Google Scholar
• Sobocka MB, Sobocki T, Babinska A, Hartwig JH, Li M, Ehrlich YH, Kornecki E. Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa. J Recept Signal Transduct Res. 2004;24(1–2):85–105. doi:10.1081/RRS-120034252. Epub 2004 Sep 4.
   PubMed Web of Science ®Google Scholar
• Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N, Reiss K, Sarabi A, Lindbom L, Hackeng TM, et al. Regulated release and functional modulation of junctional adhesion molecule a by disintegrin metalloproteinases. Blood. 2009;113(19):4799–809. doi:10.1182/blood-2008-04-152330. Epub 2009 Mar 5.
   PubMed Web of Science ®Google Scholar
• Sobocki T, Sobocka MB, Babinska A, Ehrlich YH, Banerjee P, Kornecki E. Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/JAM-A. Gene. 2006;366(1):128–44. doi:10.1016/j.gene.2005.08.025. Epub 2005 Dec 13.
   PubMed Web of Science ®Google Scholar
• Prota AE, Campbell JA, Schelling P, Forrest JC, Watson MJ, Peters TR, Aurrand-Lions M, Imhof BA, Dermody TS, Stehle T. Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci U S A. 2003;100(9):5366–71. doi:10.1073/pnas.0937718100. Epub 2003 Apr 17.
   PubMed Web of Science ®Google Scholar
• Ebnet K. Junctional adhesion molecules (JAMs): cell adhesion receptors with pleiotropic functions in cell physiology and development. Physiol Rev. 2017;97(4):1529–54. doi:10.1152/physrev.00004.2017. Epub 2017 Sep 22.
   PubMed Web of Science ®Google Scholar
• Bonilha CS, Benson RA, Brewer JM, Garside P. Targeting opposing immunological roles of the junctional adhesion molecule-a in autoimmunity and cancer. Front Immunol. 2020;11:602094. doi:10.3389/fimmu.2020.602094. Epub 2020 Dec 17.
   PubMed Web of Science ®Google Scholar
• Ebnet K, Suzuki A, Ohno S, Vestweber D. Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci. 2004;117(1):19–29. doi:10.1242/jcs.00930. Epub 2003 Dec 06.
   PubMed Web of Science ®Google Scholar
• Kostrewa D, Brockhaus M, D’Arcy A, Dale GE, Nelboeck P, Schmid G, Mueller F, Bazzoni G, Dejana E, Bartfai T, et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. Embo J. 2001;20(16):4391–8. doi:10.1093/emboj/20.16.4391. Epub 2001 Aug 14.
   PubMed Web of Science ®Google Scholar
• Monteiro AC, Luissint AC, Sumagin R, Lai C, Vielmuth F, Wolf MF, Laur O, Reiss K, Spindler V, Stehle T, et al. Trans-dimerization of JAM-A regulates Rap2 and is mediated by a domain that is distinct from the cis-dimerization interface. Mol Biol Cell. 2014;25(10):1574–85. doi:10.1091/mbc.e14-01-0018. Epub 2014 Mar 29.
   PubMed Web of Science ®Google Scholar
• Steinbacher T, Kummer D, Ebnet K. Junctional adhesion molecule-A: functional diversity through molecular promiscuity. Cell Mol Life Sci. 2018;75(8):1393–409. doi:10.1007/s00018-017-2729-0. Epub 2017 Dec 15.
   PubMed Web of Science ®Google Scholar
• Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol. 2007;7(6):467–77. doi:10.1038/nri2096. Epub 2007 May 26.
   PubMed Web of Science ®Google Scholar
• Bazzoni G, Martinez-Estrada OM, Mueller F, Nelboeck P, Schmid G, Bartfai T, Dejana E, Brockhaus M. Homophilic interaction of junctional adhesion molecule. J Biol Chem. 2000;275(40):30970–6. doi:10.1074/jbc.M003946200. Epub 2000 Jul 27.
   PubMed Web of Science ®Google Scholar
• Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH, Crompton A, Chan AC, Anderson JM, Cantley LC. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science. 1997;275(5296):73–7. doi:10.1126/science.275.5296.73. Epub 1997 Jan 03.
   PubMed Web of Science ®Google Scholar
• Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG, Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem. 2000;275(36):27979–88. doi:10.1074/jbc.M002363200. Epub 2000 Jun 17.
   PubMed Web of Science ®Google Scholar
• Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol. 2002;3(2):151–8. doi:10.1038/ni755. Epub 2002 Jan 29.
   PubMed Web of Science ®Google Scholar
• Kobayashi I, Kobayashi-Sun J, Kim AD, Pouget C, Fujita N, Suda T, Traver D. Jam1a–jam2a interactions regulate haematopoietic stem cell fate through Notch signalling. Nature. 2014;512(7514):319–23. doi:10.1038/nature13623. Epub 2014 Aug 15.
   PubMed Web of Science ®Google Scholar
• Salifu MO, Kolff Q, Murty P, Haria DM, Zimpa M, Shakeel M, Lee H, Kornecki E, Babinska A. Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients. J Investig Med. 2007;55(3):115–19. doi:10.2310/6650.2007.06041. Epub 2007 May 08.
   PubMed Web of Science ®Google Scholar
• Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, Speicher KD, Blair IA, Speicher DW, Grosser T, et al. Deciphering the human platelet sheddome. Blood. 2011;117(1):e15–26. doi:10.1182/blood-2010-05-283838. Epub 2010 Oct 22.
   PubMed Web of Science ®Google Scholar
• Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF. The platelet microparticle proteome. J Proteome Res. 2005;4(5):1516–21. doi:10.1021/pr0500760. Epub 2005 Oct 11.
   PubMed Web of Science ®Google Scholar
• Rath D, Rapp V, Schwartz J, Winter S, Emschermann F, Arnold D, Rheinlaender J, Buttcher M, Strebl M, Braun MB, et al. Homophilic interaction between transmembrane-JAM-A and soluble jam-a regulates thrombo-inflammation: implications for coronary artery disease. JACC Basic Transl Sci. 2022;7(5):445–61. doi:10.1016/j.jacbts.2022.03.003. Epub 2022 Jun 7.
   PubMedGoogle Scholar
• Peddibhotla SS, Brinkmann BF, Kummer D, Tuncay H, Nakayama M, Adams RH, Gerke V, Ebnet K. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor–specific angiogenic signaling. Mol Biol Cell. 2013;24(7):933–44. doi:10.1091/mbc.e12-06-0481. Epub 2013 Feb 8.
   PubMed Web of Science ®Google Scholar
• Tholmann S, Seebach J, Otani T, Florin L, Schnittler H, Gerke V, Furuse M, Ebnet K. JAM-A interacts with α3β1 integrin and tetraspanins CD151 and CD9 to regulate collective cell migration of polarized epithelial cells. Cell Mol Life Sci. 2022;79(2):88. doi:10.1007/s00018-022-04140-5. Epub 2022 Jan 25.
   PubMed Web of Science ®Google Scholar
• Naik MU, Mousa SA, Parkos CA, Naik UP. Signaling through JAM-1 and αvβ3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and αvβ3 complex. Blood. 2003;102(6):2108–14. doi:10.1182/blood-2003-04-1114. Epub 2003 May 17.
   PubMed Web of Science ®Google Scholar
• Mangin PH, Kleitz L, Boucheix C, Gachet C, Lanza F. CD9 negatively regulates integrin αIIbβ3 activation and could thus prevent excessive platelet recruitment at sites of vascular injury. J Thromb Haemost. 2009;7(5):900–2. doi:10.1111/j.1538-7836.2009.03322.x. Epub 2009 Feb 21.
   PubMed Web of Science ®Google Scholar
• Severson EA, Lee WY, Capaldo CT, Nusrat A, Parkos CA. Junctional adhesion molecule a interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate β1 integrin levels, and enhance cell migration. Mol Biol Cell. 2009;20(7):1916–25. doi:10.1091/mbc.e08-10-1014. Epub 2009 Jan 30.
   PubMed Web of Science ®Google Scholar
• Monteiro AC, Sumagin R, Rankin CR, Leoni G, Mina MJ, Reiter DM, Stehle T, Dermody TS, Schaefer SA, Hall RA, et al. JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function. Mol Biol Cell. 2013;24(18):2849–60. doi:10.1091/mbc.e13-06-0298. Epub 2013 Jul 26.
   PubMed Web of Science ®Google Scholar
• Martinez-Estrada OM, Villa A, Breviario F, Orsenigo F, Dejana E, Bazzoni G. Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J Biol Chem. 2001;276(12):9291–6. doi:10.1074/jbc.M006991200. Epub 2000 Dec 30.
   PubMed Web of Science ®Google Scholar
• Hamazaki Y, Itoh M, Sasaki H, Furuse M, Tsukita S. Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem. 2002;277(1):455–61. doi:10.1074/jbc.M109005200. Epub 2001 Nov 2.
   PubMed Web of Science ®Google Scholar
• Itoh M, Sasaki H, Furuse M, Ozaki H, Kita T, Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol. 2001;154(3):491–7. doi:10.1083/jcb.200103047. Epub 2001 Aug 8.
   PubMed Web of Science ®Google Scholar
• Czubak-Prowizor K, Babinska A, Swiatkowska M. The F11 receptor (F11R)/junctional adhesion molecule-A (JAM-A) (F11R/JAM-A) in cancer progression. Mol Cell Biochem. 2022;477(1):79–98. doi:10.1007/s11010-021-04259-2. Epub 2021 Sep 18.
   PubMed Web of Science ®Google Scholar
• Hartmann C, Schwietzer YA, Otani T, Furuse M, Ebnet K. Physiological functions of junctional adhesion molecules (JAMs) in tight junctions. Biochim Biophys Acta Biomembr. 2020;1862(9):183299. doi:10.1016/j.bbamem.2020.183299. Epub 2020 Apr 06.
   PubMed Web of Science ®Google Scholar
• Babinska A, Kedees MH, Athar H, Ahmed T, Batuman O, Ehrlich YH, Hussain MM, Kornecki E. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost. 2002;88(11):843–50. doi:10.1055/s-0037-1613312. Epub 2002 Nov 13.
   PubMedGoogle Scholar
• Schmitt MM, Megens RT, Zernecke A, Bidzhekov K, van den Akker NM, Rademakers T, van Zandvoort MA, Hackeng TM, Koenen RR, Weber C. Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation. 2014;129(1):66–76. doi:10.1161/CIRCULATIONAHA.113.004149. Epub 2013 Sep 26.
   PubMed Web of Science ®Google Scholar
• Weber C. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J Mol Med (Berl). 2003;81(1):4–19. doi:10.1007/s00109-002-0391-x. Epub 2003 Jan 25.
   PubMed Web of Science ®Google Scholar
• Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, Fruscella P, Adorini L, Martino G, Furlan R, De Simoni MG, et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med. 1999;190(9):1351–6. doi:10.1084/jem.190.9.1351. Epub 1999 Nov 02.
   PubMed Web of Science ®Google Scholar
• Lamagna C, Meda P, Mandicourt G, Brown J, Gilbert RJ, Jones EY, Kiefer F, Ruga P, Imhof BA, Aurrand-Lions M. Dual Interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. Mol Biol Cell. 2005;16(10):4992–5003. doi:10.1091/mbc.e05-04-0310. Epub 2005 Aug 12.
   PubMed Web of Science ®Google Scholar
• Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C. The functional interaction of the β2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the i domain. J Immunol. 2004;173(10):6259–64. doi:10.4049/jimmunol.173.10.6259. Epub 2004 Nov 6.
   PubMed Web of Science ®Google Scholar
• Wojcikiewicz EP, Koenen RR, Fraemohs L, Minkiewicz J, Azad H, Weber C, Moy VT. LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys J. 2009;96(1):285–93. doi:10.1529/biophysj.108.135491. Epub 2008 Oct 14.
   PubMed Web of Science ®Google Scholar
• Watkins NA, Gusnanto A, de Bono B, De S, Miranda-Saavedra D, Hardie DL, Angenent WG, Attwood AP, Ellis PD, Erber W, et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood. 2009;113(19):e1–e9. doi:10.1182/blood-2008-06-162958. Epub 2009 Feb 21.
   PubMed Web of Science ®Google Scholar
• Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA. Proteomic analysis of platelet α-granules using mass spectrometry. J Thromb Haemost. 2007;5(9):1945–55. doi:10.1111/j.1538-7836.2007.02690.x. Epub 2007 Aug 29.
   PubMed Web of Science ®Google Scholar
• Huang J, Swieringa F, Solari FA, Provenzale I, Grassi L, De Simone I, Baaten C, Cavill R, Sickmann A, Frontini M, et al. Assessment of a complete and classified platelet proteome from genome-wide transcripts of human platelets and megakaryocytes covering platelet functions. Sci Rep. 2021;11(1):12358. doi:10.1038/s41598-021-91661-x. Epub 2021 Jun 13.
   PubMed Web of Science ®Google Scholar
• Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73–82. doi:10.1182/blood-2012-04-416594. Epub 2012 Aug 8.
   PubMed Web of Science ®Google Scholar
• Dale GL, Remenyi G, Friese P. Tetraspanin CD9 is required for microparticle release from coated-platelets. Platelets. 2009;20(6):361–6. doi:10.1080/09537100903096692. Epub 2009 Aug 07.
   PubMed Web of Science ®Google Scholar
• Naik MU, Caplan JL, Naik UP. Junctional adhesion molecule-A suppresses platelet integrin αIIbβ3 signaling by recruiting Csk to the integrin-c–Src complex. Blood. 2014;123(9):1393–402. doi:10.1182/blood-2013-04-496232. Epub 2013 Dec 5.
   PubMed Web of Science ®Google Scholar
• Ozaki H, Ishii K, Arai H, Horiuchi H, Kawamoto T, Suzuki H, Kita T. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation. Biochem Biophys Res Commun. 2000;276(3):873–8. doi:10.1006/bbrc.2000.3574. Epub 2000 Oct 12.
   PubMed Web of Science ®Google Scholar
• Karshovska E, Zhao Z, Blanchet X, Schmitt MM, Bidzhekov K, Soehnlein O, von Hundelshausen P, Mattheij NJ, Cosemans JM, Megens RT, et al. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice. Circ Res. 2015;116(4):587–99. doi:10.1161/CIRCRESAHA.116.304035. Epub 2014 Dec 5.
   PubMed Web of Science ®Google Scholar
• Izquierdo I, Barrachina MN, Hermida-Nogueira L, Casas V, Moran LA, Lacerenza S, Pinto-Llorente R, Eble JA, de Los Rios V, Dominguez E, et al. A comprehensive tyrosine phosphoproteomic analysis reveals novel components of the platelet CLEC-2 signaling cascade. Thromb Haemost. 2020;120(2):262–76. doi:10.1055/s-0039-3400295. Epub 2020 Jan 5.
   PubMed Web of Science ®Google Scholar
• Beck F, Geiger J, Gambaryan S, Solari FA, Dell’Aica M, Loroch S, Mattheij NJ, Mindukshev I, Potz O, Jurk K, et al. Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017;129(2):e1–e12. doi:10.1182/blood-2016-05-714048. Epub 2017 Jan 7.
   PubMed Web of Science ®Google Scholar
• Naik MU, Stalker TJ, Brass LF, Naik UP. JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets. Blood. 2012;119(14):3352–60. doi:10.1182/blood-2011-12-397398. Epub 2012 Jan 25.
   PubMed Web of Science ®Google Scholar
• Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ. Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton. J Cell Biol. 2002;157(2):265–75. doi:10.1083/jcb.200112113. Epub 2002 Apr 10.
   PubMed Web of Science ®Google Scholar
• Azari BM, Marmur JD, Salifu MO, Ehrlich YH, Kornecki E, Babinska A. Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines. J Transl Med. 2011;9(1):98. doi:10.1186/1479-5876-9-98. Epub 2011 Jun 28.
   PubMedGoogle Scholar
• Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005;25(7):1512–18. doi:10.1161/01.ATV.0000170133.43608.37. Epub 2005 May 14.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Liehn EA, Fraemohs L, von Hundelshausen P, Koenen RR, Corada M, Dejana E, Weber C. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol. 2006;26(2):e10–e13. doi:10.1161/01.ATV.0000197852.24529.4f. Epub 2005 Nov 25.
   PubMed Web of Science ®Google Scholar
• Babinska A, Clement CC, Swiatkowska M, Szymanski J, Shon A, Ehrlich YH, Kornecki E, Salifu MO. Development of new antiatherosclerotic and antithrombotic drugs utilizing F11 receptor (F11R/JAM-A) peptides. Biopolymers. 2014;102(4):322–34. doi:10.1002/bip.22503. Epub 2014 May 8.
   PubMed Web of Science ®Google Scholar
• Babinska A, Clement CC, Li Y, Wzorek J, Przygodzki T, Talar M, Braun M, Swiatkowska M, Ehrlich YH, Kornecki E, et al. In vivo data: treatment with the F11R/JAM-A peptide 4D decreases mortality and reduces the generation of atherosclerotic plaques in ApoE-deficient mice. Data Brief. 2020;30:105516. doi:10.1016/j.dib.2020.105516. Epub 2020 May 13.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Vajen T, Karshovska E, Dickhout A, Schmitt MM, Megens RTA, von Hundelshausen P, Koeppel TA, Hackeng TM, Weber C, et al. Deletion of junctional adhesion molecule a from platelets increases early-stage neointima formation after wire injury in hyperlipidemic mice. J Cell Mol Med. 2017;21(8):1523–31. doi:10.1111/jcmm.13083. Epub 2017 Feb 18.
   PubMed Web of Science ®Google Scholar
• Cavusoglu E, Kornecki E, Sobocka MB, Babinska A, Ehrlich YH, Chopra V, Yanamadala S, Ruwende C, Salifu MO, Clark LT, et al. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. J Am Coll Cardiol. 2007;50(18):1768–76. doi:10.1016/j.jacc.2007.05.051. Epub 2007 Oct 30.
   PubMed Web of Science ®Google Scholar
• Lewandrowski U, Wortelkamp S, Lohrig K, Zahedi RP, Wolters DA, Walter U, Sickmann A. Platelet membrane proteomics: a novel repository for functional research. Blood. 2009;114(1):e10–e19. doi:10.1182/blood-2009-02-203828. Epub 2009 May 14.
   PubMed Web of Science ®Google Scholar
• Nagy MB M, Poulter N, Sickmann A, Stephenne X, Brouns S, Koenen R, Ten Cate H, Heemskerk J, Baaten C. ZO-2 enriched tight junction-like structures at sites of platelet-platelet contact. The ISTH 2022 Congress; London. 2022.
   Google Scholar
• Lam FW, Vijayan KV, Rumbaut RE. Platelets and their interactions with other immune cells. Compr Physiol. 2015;5:1265–80. Epub 2015 Jul 4.
   PubMed Web of Science ®Google Scholar
• Ponomarev ED. Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and tregs during tissue inflammation. Front Immunol. 2018;9:406. doi:10.3389/fimmu.2018.00406. Epub 2018 Mar 31.
   PubMed Web of Science ®Google Scholar
• Bonilha CS, Benson RA, Scales HE, Brewer JM, Garside P. Junctional adhesion molecule-A on dendritic cells regulates Th1 differentiation. Immunol Lett. 2021;235:32–40. doi:10.1016/j.imlet.2021.05.001. Epub 2021 May 18.
   PubMed Web of Science ®Google Scholar
• Dustin ML. The immunological synapse. Cancer Immunol Res. 2014;2(11):1023–33. doi:10.1158/2326-6066.CIR-14-0161. Epub 2014 Nov 5.
   PubMed Web of Science ®Google Scholar
• Scott DW, Tolbert CE, Burridge K. Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF. Mol Biol Cell. 2016;27(9):1420–30. doi:10.1091/mbc.E15-12-0833. Epub 2016 Mar 18.
   PubMed Web of Science ®Google Scholar